Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 332,854 | 195,734 | 65,395 | 27,733 | 47,129 |
| Marketable Securities | 116,343 | 165,899 | 83,247 | N/A | N/A |
| Receivables | 247,192 | 261,243 | 234,085 | 209,282 | 194,400 |
| Inventories | 212,342 | 205,512 | 190,258 | 166,372 | 139,179 |
| Income taxes - deferred | 30,984 | 25,727 | 31,056 | 37,052 | 27,537 |
| TOTAL | $1,008,211 | $908,460 | $655,398 | $466,614 | $430,828 |
| Non-Current Assets | |||||
| PPE Net | 180,258 | 202,324 | 179,123 | 142,235 | 132,974 |
| Intangibles | 141,725 | 171,914 | 81,754 | 69,519 | 77,703 |
| Other Non-Current Assets | 96,388 | 88,920 | 76,321 | 42,335 | 42,523 |
| TOTAL | $418,371 | $463,158 | $337,198 | $254,089 | $253,200 |
| Total Assets | $1,426,582 | $1,371,618 | $992,596 | $720,703 | $684,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 391 | 402 | 208 | 760 | 5,720 |
| Accounts payable and accrued liabilities | 72,950 | 71,194 | 53,995 | 50,233 | 64,903 |
| Accrued Expenses | 81,076 | 79,061 | 71,650 | 62,800 | 58,434 |
| Other current liabilities | 55,822 | 50,511 | 48,183 | 71,392 | 47,205 |
| TOTAL | $319,243 | $315,375 | $239,252 | $208,930 | $199,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | 425,687 | 425,979 | 225,835 | 105,768 | 188,423 |
| Other Non-Current Liabilities | 21,397 | 28,988 | 16,899 | 13,079 | 0 |
| TOTAL | $449,365 | $459,355 | $257,537 | $128,686 | $201,045 |
| Total Liabilities | $768,608 | $774,730 | $496,789 | $337,616 | $400,151 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,286 | 25,891 | 25,650 | 25,295 | 24,974 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | 570,807 | 489,254 | 421,012 | 344,841 | 276,554 |
| Other shareholders' equity | 27,052 | 58,003 | 32,628 | 2,102 | -22,850 |
| TOTAL | $657,974 | $596,888 | $495,807 | $383,087 | $283,877 |
| Total Liabilities And Equity | $1,426,582 | $1,371,618 | $992,596 | $720,703 | $684,028 |